Rabinowitz Matthew
Saledirector · EXECUTIVE CHAIRMAN
- Shares
- 800
- Price
- $325.01
- Value
- $260.01K
- Date
- Sep 11, 2026
SEC FORM 4
Natera, Inc. Common Stock (NTRA) insider transactions
Recent insider purchases and sales reported on SEC Form 4, with transaction date, insider, role, shares, price and a direct SEC source for every row.
Last updated: 09/12/2026, 06:35 AM UTCAll NTRA stock data
- Recent transactions
- 12
- Insiders
- 4
- Purchases / sales
- 0 / 12
- Reported transaction value
- $24.96M
SEC Form 4 transactions
Newest filings first| Date | Insider / role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Rabinowitz Matthew director · EXECUTIVE CHAIRMAN | Sale | 800 | $325.01 | $260.01K | SEC ↗ |
| Sep 11, 2026 | Rabinowitz Matthew director · EXECUTIVE CHAIRMAN | Sale | 3,647 | $326.11 | $1.19M | SEC ↗ |
| Sep 11, 2026 | Rabinowitz Matthew director · EXECUTIVE CHAIRMAN | Sale | 10,556 | $327.14 | $3.45M | SEC ↗ |
| Sep 11, 2026 | Rabinowitz Matthew director · EXECUTIVE CHAIRMAN | Sale | 17,933 | $327.97 | $5.88M | SEC ↗ |
| Sep 11, 2026 | Rabinowitz Matthew director · EXECUTIVE CHAIRMAN | Sale | 15,764 | $328.95 | $5.19M | SEC ↗ |
| Sep 11, 2026 | Rabinowitz Matthew director · EXECUTIVE CHAIRMAN | Sale | 1,300 | $329.62 | $428.51K | SEC ↗ |
| Sep 02, 2026 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale | 15,160 | $326.89 | $4.96M | SEC ↗ |
| Sep 01, 2026 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,000 | $319.76 | $319.76K | SEC ↗ |
| Sep 01, 2026 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,400 | $320.92 | $449.29K | SEC ↗ |
| Sep 01, 2026 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale | 600 | $321.91 | $193.14K | SEC ↗ |
| Sep 01, 2026 | Chapman Steven Leonard director · CEO AND PRESIDENT | Sale | 1,698 | $320.99 | $545.04K | SEC ↗ |
| Aug 10, 2026 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale | 6,517 | $321.53 | $2.1M | SEC ↗ |
Rabinowitz Matthew
Saledirector · EXECUTIVE CHAIRMAN
- Shares
- 3,647
- Price
- $326.11
- Value
- $1.19M
- Date
- Sep 11, 2026
Rabinowitz Matthew
Saledirector · EXECUTIVE CHAIRMAN
- Shares
- 10,556
- Price
- $327.14
- Value
- $3.45M
- Date
- Sep 11, 2026
Rabinowitz Matthew
Saledirector · EXECUTIVE CHAIRMAN
- Shares
- 17,933
- Price
- $327.97
- Value
- $5.88M
- Date
- Sep 11, 2026
Rabinowitz Matthew
Saledirector · EXECUTIVE CHAIRMAN
- Shares
- 15,764
- Price
- $328.95
- Value
- $5.19M
- Date
- Sep 11, 2026
Rabinowitz Matthew
Saledirector · EXECUTIVE CHAIRMAN
- Shares
- 1,300
- Price
- $329.62
- Value
- $428.51K
- Date
- Sep 11, 2026
Moshkevich Solomon
SalePRESIDENT, CLINICALDIAGNOSTICS
- Shares
- 15,160
- Price
- $326.89
- Value
- $4.96M
- Date
- Sep 02, 2026
Moshkevich Solomon
SalePRESIDENT, CLINICALDIAGNOSTICS
- Shares
- 1,000
- Price
- $319.76
- Value
- $319.76K
- Date
- Sep 01, 2026
Moshkevich Solomon
SalePRESIDENT, CLINICALDIAGNOSTICS
- Shares
- 1,400
- Price
- $320.92
- Value
- $449.29K
- Date
- Sep 01, 2026
Moshkevich Solomon
SalePRESIDENT, CLINICALDIAGNOSTICS
- Shares
- 600
- Price
- $321.91
- Value
- $193.14K
- Date
- Sep 01, 2026
Chapman Steven Leonard
Saledirector · CEO AND PRESIDENT
- Shares
- 1,698
- Price
- $320.99
- Value
- $545.04K
- Date
- Sep 01, 2026
Fesko John
SalePRESIDENT, CHIEF BUS. OFFICER
- Shares
- 6,517
- Price
- $321.53
- Value
- $2.1M
- Date
- Aug 10, 2026
How to read this dataset
Only transactions explicitly classified as purchase (P) or sale (S) are shown. A filing does not guarantee the insider's outlook or future investment performance.